Stay updated with breaking news from Alimera Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a report released on Saturday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued research reports about the stock. Craig Hallum decreased their target price on shares of Alimera Sciences from […]
StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other brokerages have also commented on ALIM. Alliance Global Partners upgraded shares of Alimera Sciences from a neutral rating to a buy rating […]
Analysts’ new coverage for Saturday, June 17th: StockNews.com started coverage on shares of ATA Creativity Global (NASDAQ:AACG). They issued a sell rating on the stock. StockNews.com initiated coverage on shares of Atlantic American (NASDAQ:AAME). The firm issued a hold rating on the stock. StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS). They issued a […]
Alimera Sciences (NASDAQ:ALIM – Get Rating) was upgraded by equities research analysts at Alliance Global Partners from a “neutral” rating to a “buy” rating in a note issued to investors on Monday, The Fly reports. Other research analysts also recently issued research reports about the company. HC Wainwright cut their target price on Alimera Sciences […]
Alimera Sciences, Inc. (NASDAQ:ALIM – Get Rating) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 791,600 shares, a growth of 3,157.6% from the May 15th total of 24,300 shares. Based on an average daily trading volume, of 606,100 shares, […]